Abstract
Although the prolonged survival of experimental composite tissue allografts (CTAs) is achievable using immunosuppressive drugs, long-term immunosuppression of CTAs is not acceptable in the clinical setting because of serious side-effects. The development of a model for reliable CTA tolerance induction across a major histocompatibility complex (MHC) mismatch and without the need for long-term immunosuppression is highly desirable.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Starzl TE, Demetris AJ, Murase N et al (1992) Cell migration, chimerism, and graft acceptance. Lancet 339:1579–1582
Monaco AP (2003) Chimerism in organ transplantation: conflicting experiments and clinical observations. Transplantation 75:13–16
Muramatsu K, Kurokawa Y, Ihara K et al (2005) Donor cell engraftment in recipient lymphoid tissues after rat limb allograft. J Surg Res 124:38–44
Muramatsu K, Bishop AT, Sunagawa T, Valenzuela RG (2003) Fate of donor cells in vascularized bone grafts: identification of systemic chimerism by the polymerase chain reaction. Plast Reconstr Surg 111:763–772
Muramatsu K, Valenzuela RG, Bishop AT (2003) Detection of chimerism following vascularized bone allotransplantation by polymerase chain reaction using a Y-chromosome specific primer. J Orthop Res 21:1056–1062
Foster RD, Ascher NL, McCalmont TH et al (2001) Mixed allogeneic chimerism as a reliable model for composite tissue allograft tolerance induction across major and minor histocompatibility barriers. Transplantation 72:791–797
Foster RD, Fan L, Neipp M et al (1998) Donor-specific tolerance induction in composite tissue allografts. Am J Surg 176:418–421
Takahashi M, Hakamata Y, Takeuchi K, Kobayashi E (2003) Effects of different fixatives on beta-galactosidase activity. J Histochem Cytochem 51:553–554
Takahashi M, Hakamata Y, Kobayashi E et al (2003) Establishment of lacZ-transgenic rats: a tool for regenerative research in myocardium. Biochem Biophys Res Commun 305:904–908
Muramatsu K, Doi K, Kawai S et al (1999) Limb allotransplantation in rats: combined immunosuppression by FK-506 and 15-deoxyspergualin. J Hand Surg 24:586–593
Colson YL, Zadach, K, Nalesnik M, Ildstad ST (1995) Mixed allogeneic chimerism in the rat. Donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts. Transplantation 60:971–980
Hewitt CW, Ramsamooj R, Black KS et al (1990) Development of stable mixed T cell chimerism and transplantation tolerance without immune modulation in recipients of vascularized bone marrow allografts. Transplantation 50:766–772
Esumi T, Inaba M, Ikehara S et al (2003) Successful allogeneic leg transplantation in rats in conjunction with intra-bone marrow injection of donor bone marrow cells. Transplantation 76:1543–1548
Ajiki T, Takahashi M, Kobayashi E et al (2003) Generation of donor hematolymphoid cells after rat-limb composite grafting. Transplantation 75:631–636
Mathes DW, Randolph MA, Lee WP et al (2002) Recipient bone marrow engraftment in donor tissue after long-term tolerance to a composite tissue allograft. Transplantation 73:1880–1885
Granger DK, Breidenbach WC, Kaufman CL et al (2002) Lack of donor hyporesponsiveness and donor chimerism after clinical transplantation of the hand. Transplantation 74:1624–1630
Tomita Y, Nomoto K (1990) Induction of tolerance to non-H-2 alloantigens is not restricted by the MHC molecules expressed on the donor cells in cyclophosphamide-induced tolerance. Immunobiology 181:430–437
Zhang QW, Mayumi H, Yasui H et al (1997) Fractionated dosing of cyclophosphamide for establishing long-lasting skin allograft survival, stable mixed chimerism, and intrathymic clonal deletion in mice primed with allogeneic spleen cells. Transplantation 63:1667–1673
Mayumi H, Umesue M, Nomoto K (1996) Cyclophosphamide-induced immunological tolerance: an overview. Immunobiology 195:129–139
Iwai T, Tomita Y, Yasui H et al (2005) Requirement of a higher degree of chimerism for skin allograft tolerance in cyclophosphamide-induced tolerance. Transpl Int 17:795–803
Okayama J, Ko S, Nakajima Y et al (2004) Bone marrow chimerism and tolerance induced by single-dose cyclophosphamide. J Surg Res 120:102–110
Okabe T, Nomura H, Sato N, Ohsawa N et al (1982) Large-scale preparation and characterization of human colony-stimulating factor. J Cell Physiol 110:43–49
Ramsamooj R, Llull R, Black KS, Hewitt CW (1999) Composite tissue allografts in rats: IV. Graft-versus-host disease in recipients of vascularized bone marrow transplants. Plast Reconstr Surg 104:1365–1371
Gorantla VS, Prabhune KA, Barker JH et al (2003) Composite tissue allotransplantation in chimeric hosts: part I. Prevention of graft-versus-host disease. Transplantation 75:922–932
Prabhune KA, Gorantla VS, Maldonado C et al (2003) Composite tissue allotransplantation in chimeric hosts. Part II. A clinically relevant protocol to induce tolerance in a rat model. Transplantation 76:1548–1555
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer-Verlag Italia
About this chapter
Cite this chapter
Muramatsu, K., Doi, K., Tanaka, H., Taguchi, T. (2007). Induction of High-Level Chimerism in Composite Tissue Transplants. In: Lanzetta, M., Dubernard, JM., Petruzzo, P. (eds) Hand Transplantation. Springer, Milano. https://doi.org/10.1007/978-88-470-0374-3_5
Download citation
DOI: https://doi.org/10.1007/978-88-470-0374-3_5
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-0373-6
Online ISBN: 978-88-470-0374-3
eBook Packages: MedicineMedicine (R0)